Discover Tenders by Iron Bridge Sections Sector

Find the most relevant tenders for Iron Bridge Sections. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Iron Bridge Sections tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Iron Bridge Sections tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6261602

EMD:Ref Document

Bid Value: Ref Document

248 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alitretinoin D11Ah04 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6230493

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Open House Contracts For Multiple Active Ingredients Active Ingredient Combinations

Deadline: 01 Jun 2026

Germany

Ref. No.: 6230074

EMD:Ref Document

Bid Value: Ref Document

35 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine J05Ar21 Within The Framework Of A So Called Open House

Deadline: 31 May 2026

Germany

Ref. No.: 6229869

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Deadline: 31 Dec 2026

Germany

Ref. No.: 6229837

EMD:Ref Document

Bid Value: Ref Document

248 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab C10Ax14 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6227129

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bempedoic Acid C10Ax15 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6227068

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lisdexamfetamine N06Ba12 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6225281

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Etanercept L04Ab01 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224846

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ustekinumab L04Ac05 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224416

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Bempedoic Acid And Ezetimibe C10Ba10 Within The Framework Of A So Called Open House

Deadline: 31 May 2026

Germany

Ref. No.: 6223493

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V Open House Model

Deadline: 01 Jun 2026

Germany

Ref. No.: 6223117

EMD:Ref Document

Bid Value: Ref Document

35 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naloxegol A06Ah03 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6222391

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 6205105

EMD:Ref Document

Bid Value: Ref Document

411 Days Left

Broad Agency Announcement Baa For Extramural Biomedical And Human Performance Research And Development Ht9425 23 S Soc1

Deadline: 31 Jul 2028

United States

Ref. No.: 6205063

EMD:Ref Document

Bid Value: Ref Document

826 Days Left

Showing 33676 to 33690 of 33909 results

‹
1
2
...
2243
2244
2245
2246
2247
2248
2249
...
2260
2261
›

Discover Tenders by Iron Bridge Sections Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Iron Bridge Sections Sector

Filter Your Search

FREE Trial plan for all new users!